Rockwell Medical Technologies Inc.
30142 Wixom Road
Wixom,
MI 48393
United States - Map
Phone: 248-960-9009
Fax: 248-960-9119
Web Site: http://www.rockwellmed.com
| Rockwell Medical Technologies, Inc. manufactures and sells hemodialysis concentrate solutions and dialysis kits to hemodialysis providers, targeting end-stage renal disease, chronic kidney disease, and iron deficiency anemia in the United States and internationally. It manufactures, sells, distributes, and delivers hemodialysis concentrates, as well as a line of ancillary hemodialysis products to hemodialysis providers and distributors located in 37 states and territories, as well as various countries, primarily in Latin America, Asia, and Europe. Hemodialysis duplicates kidney function in patients with failing kidneys, known as end stage renal disease, an advanced stage of chronic kidney disease characterized by the irreversible loss of kidney function. It offers Renal Pure liquid acid concentrates, Dri-Sate dry acid concentrate and mixing system, RenalPure powder bicarbonate concentrate, and SteriLyte liquid bicarbonate concentrate, as well as a range of ancillary products, including blood tubing, fistula needles, specialized custom kits, dressings, cleaning agents, filtration salts, and other supplies used by hemodialysis providers. Rockwell Medical Technologies sells its products through direct salespeople and independent sales representation companies; and to certain international customers through independent sales agents and distributors. The company was founded in 1995 and is based in Wixom, Michigan. |
|
| Key Statistics |
| |
| | Pay | Exercised | Mr. Robert L. Chioini , 45
Founder, Chairman, Chief Exec. Officer, Pres and Member of Stock Option Committee |
N/A
| N/A | Mr. Thomas E. Klema , 56
Chief Financial Officer, Principal Accounting Officer, VP of Fin., Sec. and Treasurer |
N/A
| N/A | Dr. Ajay Gupta MD,
Chief Scientific Officer and Member of Scientific Advisory Board |
N/A
| N/A | Dr. Richard C. Yocum M.D., 54
VP of Drug Devel. & Medical Affairs |
N/A
| N/A |
|
|
|
Dollar amounts are as of
31-Dec-08
and compensation values are for the last fiscal
year ending on that date. "Pay" is salary, bonuses, etc. "Exercised" is the value of
options exercised during the fiscal year.
| |
|
0.31% Nasdaq 
0.05 (0.86%) 
Profile
